Compound heterozygous <scp> <i>SLC12A5</i> </scp> variants expand the molecular and functional spectrum of <scp>KCC2</scp> ‐developmental and epileptic encephalopathy

OBJECTIVE: This study was undertaken to characterize the functional impact of novel SLC12A5 variants in two unrelated patients with early onset developmental and epileptic encephalopathy (DEE) and to investigate the mechanisms underlying KCC2 dysfunction. METHODS: Clinical, genetic, and functional analyses were performed in two patients (Cases A and B) with DEE. SLC12A5 encodes two KCC2 splice isoforms (KCC2a and KCC2b). Functional effects of the identified variants on KCC2b ion transport, phosphorylation, mRNA processing, and KCC2-dependent synaptogenesis were assessed using in vitro assays in heterologous expression systems and primary neurons, supported by in silico structural modeling. RESULTS: Both patients developed severe neonatal onset DEE characterized by developmental delay, axial hypotonia, extrapyramidal features, and bilateral migratory seizures within 24 h of birth. Both cases resulted in early mortality (Case A at 9 years; Case B at 6 months). Sequencing revealed distinct biallelic compound heterozygous SLC12A5 variants in both individuals, each inherited from one unaffected parent. Functional analyses demonstrated that in Case A, one variant markedly reduced KCC2-mediated ion transport, whereas the second variant preserved transport activity but exhibited an altered phosphorylation profile at Ser940, located on the intracellular C-terminal region. This variant also disrupted wild-type (WT) KCC2-dependent excitatory synapse formation in immature rat hippocampal neurons. In Case B, one variant disrupted normal mRNA transcript processing consistent with loss of expression, and the second variant exhibited reduced ion transport activity. SIGNIFICANCE: These data demonstrate that SLC12A5-related DEE can result from combined impairment of KCC2-dependent chloride homeostasis and disruption of chloride-independent KCC2 functions critical for early neuronal development. This work expands the mutational and mechanistic spectrum of SLC12A5-DEE and highlights the importance of KCC2 regulatory roles in early brain development, providing new knowledge and tools for basic research and potential avenues for targeted precision therapies.

Authors

Institutions

Publication Details

Journal
Epilepsia
Published
2026-04-25
DOI
https://doi.org/10.1002/epi.70258
Primary Topic
Epilepsy research and treatment
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Compound heterozygous SLC12A5 variants expand the molecular and functional spectrum of KCC2 ‐developmental and epileptic encephalopathy

Eudéline Alix, Perrine Friedel, Dorothée Ville, Éric Denarier et al.
Epilepsia
Epilepsy research and treatment
article

Compound heterozygous SLC12A5 variants expand the molecular and functional spectrum of KCC2 ‐developmental and epileptic encephalopathy

Eudéline Alix, Perrine Friedel, Dorothée Ville, Éric Denarier, Robyn Whitney, Nathalie Villeneuve, Mira Hamze, Igor Medina, Gaëtan Lesca, Jens Hausmann, Sylvie Gory‐Fauré, Damien Sanlaville, Christophe Porcher, Nicolas Chatron, Cathy Brier, Anna‐Maria Hartmann, Audrey Labalme, Lisa Becker, Jinwei Zhang, Lucie I. Pisella
article en

Abstract

OBJECTIVE: This study was undertaken to characterize the functional impact of novel SLC12A5 variants in two unrelated patients with early onset developmental and epileptic encephalopathy (DEE) and to investigate the mechanisms underlying KCC2 dysfunction. METHODS: Clinical, genetic, and functional analyses were performed in two patients (Cases A and B) with DEE. SLC12A5 encodes two KCC2 splice isoforms (KCC2a and KCC2b). Functional effects of the identified variants on KCC2b ion transport, phosphorylation, mRNA processing, and KCC2-dependent synaptogenesis were assessed using in vitro assays in heterologous expression systems and primary neurons, supported by in silico structural modeling. RESULTS: Both patients developed severe neonatal onset DEE characterized by developmental delay, axial hypotonia, extrapyramidal features, and bilateral migratory seizures within 24 h of birth. Both cases resulted in early mortality (Case A at 9 years; Case B at 6 months). Sequencing revealed distinct biallelic compound heterozygous SLC12A5 variants in both individuals, each inherited from one unaffected parent. Functional analyses demonstrated that in Case A, one variant markedly reduced KCC2-mediated ion transport, whereas the second variant preserved transport activity but exhibited an altered phosphorylation profile at Ser940, located on the intracellular C-terminal region. This variant also disrupted wild-type (WT) KCC2-dependent excitatory synapse formation in immature rat hippocampal neurons. In Case B, one variant disrupted normal mRNA transcript processing consistent with loss of expression, and the second variant exhibited reduced ion transport activity. SIGNIFICANCE: These data demonstrate that SLC12A5-related DEE can result from combined impairment of KCC2-dependent chloride homeostasis and disruption of chloride-independent KCC2 functions critical for early neuronal development. This work expands the mutational and mechanistic spectrum of SLC12A5-DEE and highlights the importance of KCC2 regulatory roles in early brain development, providing new knowledge and tools for basic research and potential avenues for targeted precision therapies.

Epilepsia
Université Claude Bernard Lyon 1 (FR), Carl von Ossietzky Universität Oldenburg (DE), Lyon College (US), Commissariat à l'Énergie Atomique et aux Énergies Alternatives (FR), McMaster University Medical Centre (CA), CEA Grenoble (FR), Assistance Publique Hôpitaux de Marseille (FR), Centre de Recherche en Neurosciences de Lyon (FR), Shanghai Institute of Organic Chemistry (CN), Institut de Neurobiologie de la Méditerranée (FR), Institut NeuroMyoGène (FR), Grenoble Institute of Neurosciences (FR), Université Grenoble Alpes (FR), McMaster University (CA)
InMed Pharmaceuticals, Agence Nationale de la Recherche, Institut National de la Santé et de la Recherche Médicale, Ministère de l'Education Nationale, de l'Enseignement Superieur et de la Recherche, Conseil National de la Recherche Scientifique
Openalex Percentile: Top 9%
Epilepsy research and treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.